{
    "nct_id": "NCT04959474",
    "official_title": "SABR-CaRe: A Phase II Randomized Trial of Pre-Operative Stereotactic Ablative Radiation Therapy (SABR) With and Without Caloric Restriction for Early Stage Breast Cancer",
    "inclusion_criteria": "* Patients with pathologically proven DCIS or invasive breast cancer histologies\n* Willing and able to provide informed consent\n* Willing and able to comply with study treatments including dietary intervention\n* Body mass index (BMI) >= 21 at time of enrollment\n* Age >= 40 years at time of consent\n\n  * Patients with triple negative breast cancer (TNBC) must be >= 50 years of age at time of consent\n* Karnofsky performance status (KPS) score 70 - 100\n* Tumor size =< 3.0 cm\n* Gross disease within the breast must be unifocal\n\n  * Gross disease may be multifocal as long as the total extent of tumor, gross and microscopic, occupies a volume with greatest dimension =< 3 cm\n* Patients with invasive disease are required to have axillary staging including axillary ultrasound (US) that proves patient is clinically node negative\n* Patient is not being considered for preoperative chemotherapy\n* Must be English or Spanish speaking\nHealthy volunteers allowed\nMust have minimum age of 40 Years",
    "exclusion_criteria": "* Patient is clinically node positive: clinically suspicious axillary lymph node(s) by axillary US or exam unless biopsied and found to be negative\n* Patient has stage IV metastatic disease\n\n  * Patients with oligo-metastatic disease who are being treated with curative intent per the treating physician will not be excluded if all other eligibility criteria are met\n* Breast tumor size is > 3.0 cm\n* Positive non-axillary sentinel nodes or evidence of suspicious supraclavicular, infraclavicular, or internal mammary nodes by imaging or physical exam, unless biopsied and found to be negative for tumor\n* Evidence by physical examination or mammography of other suspicious masses, densities, or microcalcifications in either breast, unless biopsied and found to be benign\n* Paget's disease of the nipple\n* Previous breast radiation on ipsilateral side\n* Any prior treatment with radiation therapy or chemotherapy for the current breast cancer diagnosis prior to registration\n* Patients with significant psychiatric illness that would preclude them from adhering to the protocol in the judgement of the treating clinician\n* BMI < 21 at the time of study enrollment",
    "miscellaneous_criteria": ""
}